Author

Ruibao Liu

Observed names: Liu, Rui-Bao, Rui-Bao Liu

Institution: Harbin Medical University

Observed institutions: Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, Zhongda Hospital Southeast University, Chengdu University, Chengdu University of Traditional Chinese Medicine, Southeast University

ORCID: 0000-0002-8740-2306

Observed ORCID: 0000-0002-8740-2306

OpenAlex ID: A5017591670

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

2024 · Zhi-Cheng Jin, Jian-Jian Chen, et al. · EClinicalMedicine · 161

Vitamins and Mineral Supplements for Retinitis Pigmentosa

2019 · Ying Zhao, Kai Feng, et al. · Journal of Ophthalmology · 34

Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)

2025 · Zhi-Cheng Jin, Jingwei Wei, et al. · Hepatology · 15

Transarterial chemoembolization plus apatinib for unresectable hepatocellular carcinoma: a multicenter, randomized, open-label, phase III trial

2025 · Xue-Feng Kan, Bin Liang, et al. · BMC Medicine · 10

Retinal oxygen saturation and vessel diameter in patients with chronic kidney disease

2020 · Ruibao Liu, Wenyuan Jian, et al. · Acta Ophthalmologica · 9

Incidence and risk factors of pancreatitis in obstructive jaundice patients after percutaneous placement of self-expandable metallic stents

2020 · Yi Yang, Rui-Bao Liu, et al. · Hepatobiliary & pancreatic diseases international · 9

Efficacy and safety of TACE-HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for the patients with BCLC-defined stage B-C HCC

2025 · Bowen Liu, Linan Yin, et al. · Frontiers in Oncology · 4

Efficacy of transarterial chemoembolization‑hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosis

2025 · Xunbo Hou, Qiannan Xu, et al. · Oncology Letters · 2

A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021

2025 · Hong Zhao, Yilei Mao, et al. · Cancer Innovation · 1

Additional file 1 of TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysis

2026 · Ding, Rong, Xu, Xiao-Yang, et al. · Figshare

Targeting RECQL4 in hepatocellular carcinoma: from prognosis to therapeutic potential

2025 · Yingchen Li, Linan Yin, et al. · BMC Medical Genomics

Huaier granules for hepatocellular carcinoma recurrence after ablation: A multicenter prospective cohort study.

2023 · Yue Han, Jiasheng Zheng, et al. · Journal of Clinical Oncology

Works count: 12

Citation count: 245

H-index: 6

I10-index: 4